Drug Trial Radar · NCT00025935
Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder
Last checked: Nov 20, 2026Latest source record: Sep 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
2,350
Planned (sponsor's estimate)
Start
Jan 1, 2002
Primary completion
Not stated
Sponsor
- Lead sponsor
- National Institute of Mental Health (NIMH)NIH
- Sponsor type
- NIH
- First posted
- Nov 1, 2001
Design
- Study type
- Observational
- FDA-regulated drug
- No
- Who can join
- All sexes, from 7 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study seeks to learn more about the symptoms of severe mood dysregulation in children and adolescents ages 7-17. Children and adolescents with severe mood dysregulation (SMD) display chronic anger, sadness, or irritability, as well as hyperarousal (such as insomnia, distractibility, hyperactivity) and extreme responses to frustration (such as frequent, severe temper tantrums). Researchers will describe the moods and behaviors of children with these symptoms and use specialized testing and brain imaging to learn about the brain changes associated with this disorder.
Conditions
- Mood Disorder
Interventions
LithiumDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- To examine between-group differences in clinical, behavioral, genetic, neuroanatomical, and neurophysiological variablesTime frame: 20 years
- To examine associations between irritability and clinical, behavioral, genetic, neuroanatomical, and neurophysiological variablesTime frame: 20 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
National Institutes of Health Clinical Center
Bethesda, Maryland · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.